Showing results (1031-1040 of 4,725) with videos related to

Sort By:
Pageof 473
Drug Discovery Today|February 10, 2024
Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer's diseaseJunqiu He, Kin Yip Tam
Drug Discovery Today|February 10, 2024
Recent trends in targeted delivery of smart nanocarrier-based microbial enzymes for therapeutic applicationsNikita Jangra, Anubhuti Kawatra, Bharti Datten, et al.
Drug Discovery Today|February 10, 2024
Nanocrystal technologies in biomedical science: From the bench to the clinicEkta Pardhi, Ravindra Vasave, Vaibhavi Srivastava, et al.
Drug Discovery Today|April 5, 2024
DDR1-targeted therapies: current limitations and future potentialDonglin Wu, Zihui Ding, Tao Lu, et al.
Drug Discovery Today|February 22, 2024
Orphan GPR52 as an emerging neurotherapeutic targetSaghir Ali, Pingyuan Wang, Ryan E Murphy, et al.
Drug Discovery Today|February 24, 2024
A drug delivery strategy emerges that has the potential to transform cancer therapyNigel Theobald, David Templeton
Drug Discovery Today|February 1, 2024
NAFLD and NASH: etiology, targets and emerging therapiesShulin Wei, Li Wang, Paul C Evans, et al.
Drug Discovery Today|June 3, 2024
Mycobacteriophages: therapeutic approach for mycobacterial infectionsSunil Kumar Raman, D V Siva Reddy, Vikas Jain, et al.
Drug Discovery Today|May 17, 2024
The importance of a go-to-market strategy in the commercialisation of cellular immunotherapiesCristina Piñel-Neparidze, Harry Bickerstaffe, Samvar Shah, et al.
Drug Discovery Today|June 3, 2024
Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunityMarcelien H E Callenbach, Wim G Goettsch, Aukje K Mantel-Teeuwisse, et al.
Pageof 473